Searched for
BIOCON NUMBERS
JEE Advanced Result 2026 declared: Check direct link for registration, JoSAA Counselling, AAT Schedule dates and moreJEE Advanced Result 2026 out at jeeadv.ac.in: IIT Roorkee announced JEE Advanced 2026 results on May 31st. Qualified students can now regis...- Harsh Goenka shares video of Indian Railways staff arriving in just two minutes for coach cleaning, says “it restores faith in system”. Watch hereHarsh Goenka shared a viral video showcasing Indian Railways' 'Clean My Coach' service, which has garnered praise online. The clip shows ho...
- From Adani Green to Tata Tech: 50 companies swing back to profit in Q4 despite market turmoilIndian companies show strong recovery. Over 50 firms moved from losses to profits in the March quarter. This turnaround happened despite ma...
- The 20 stocks mutual funds are buying with Rs 1 lakh crore to defy historic FII sellingIndian mutual funds are investing Rs 1.07 lakh crore in 20 key stocks to counter historic FII selling. They are focusing on large-cap priva...
- Ahead of Market: 10 things that will decide stock market action on ThursdayBenchmark indices closed marginally higher on Wednesday, led by gains in banking and auto shares, while IT and FMCG stocks capped advances....
- Kiran Mazumdar-Shaw names niece Claire as successor, targets semaglutide push from FY28; debt cut to $1.1 billionBiocon's Executive Chairperson, Kiran Mazumdar-Shaw, outlined a five-year leadership transition with her niece, Claire Mazumdar, as success...
- 'Thank God' Kiran Mazumdar Shaw did not become a doctor: When Dr Devi Shetty shared a life lesson from Biocon founder's inspiring journeyA missed medical college admission propelled Kiran Mazumdar-Shaw towards a different path, ultimately leading to the founding of Biocon. Re...
- Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
- Iran war halts but missiles would echo in Q4 results: 40 stocks may report over 20% profit dipIndia's corporate earnings for the quarter ended March 2026 are feeling the economic heat from the recent Israel-US-Iran conflict. While so...
- Biocon not to rush generic semaglutide to packed India market, says incoming CEO Shreehas TambeBiocon will delay its Indian launch of semaglutide. The company is focusing on international markets for the diabetes and weight-management...
- Sanjiv Bhasin on why Biocon is a Dark Horse play and Mankind a ‘Hold’Sanjiv Bhasin says Mankind has been a revelation purely on the back of some of the launches which have been well accepted and their domesti...
- Biocon Q2 Results: Net profit drops 66% YoY to Rs 47 cr due to exceptional itemsTotal revenues rose 23% YoY for Q2FY23 at Rs 2,384 crore compared to Rs 1,945 crore in Q2FY22
- Biocon ranked among top five biotech employers globallyRanked at number five among global pharma and biotech companies in 2020, the Bengaluru-headquartered biopharmaceuticals company said it has...
- Biocon number six in top 10 Global Biotech Employers ranking for 2019Biocon continues to be the only company from Asia to feature on the prestigious US-based 'Science' magazine's annual 'Science Careers Top 2...
- Biocon teams up with Swiss drugmaker Sandoz for next gen biosimilarUnder the terms of the agreement, both companies will share responsibility for end to end development, manufacturing and global regulatory ...
- Management commentary, capex outlook hold the key for Biocon: Mayuresh JoshiIf you look at how the business model has evolved for Biocon, Syngene is the one which is driving the overall profitability for the company...
- Stock Buzz: Biocon to remain flavour of the street for short term"In terms of the technical set up for Biocon, things are looking good. It is going up on a day when other pharma stocks are under pressure."
- Bicon stock can be a really good performer: Pankaj Pandey, ICICI DirectOver the last few days, the developments have been quite positive in Biocon.
- Biocon continues to be good buy on declines: Sandeep WagleET Now spoke to Sandeep Wagle, Founder & MD, APTART Technical Advisory Services, www.aptartindia.com, for a technical check on Biocon.
- Biocon to announce numbers todayIt is earnings season and the pharma company which in recent past has done many strategic acquisitions is set to announce its Q4 numbers to...
Load More
